Dr. Charles M. Reynolds, MD

Dr. Reynolds practices at CHI St. Anthony Hospital in Pendleton, Oregon, part of CommonSpirit Health.

Dr. Reynolds' NPI, 1073770400, was assigned on May 22, 2008. Dr. Reynolds holds Oregon license MD178898.

Dr. Reynolds' primary practice is CHI St. Anthony Hospital, at 2801 St Anthony Way, Pendleton, OR 97801 in Umatilla County. The practice phone is (541) 276-5121.

Dr. Reynolds' primary practice is CHI St. Anthony Hospital in Pendleton, Oregon, part of CommonSpirit Health. Dr. Reynolds is also affiliated with Saint Alphonsus Regional Medical Center. The medical group on file is Vituity. Dmand AI also links Dr. Reynolds to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reynolds practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Reynolds' primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Reynolds is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Reynolds' licenses on file in 5 states: Oregon, California, Colorado, Idaho and New Mexico.

CMS data shows 332 Medicare services from Dr. Reynolds across 4 procedure codes in 2024, for 242 Medicare patients. Medicare paid $28,238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 242 Medicare patients who saw Dr. Reynolds in 2024. The largest group is 75 to 84, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reynolds' median patient age at 70, with 54% women.

In 2024, Dr. Reynolds wrote 171 Medicare Part D claims for 122 patients. 92% of them were for generic drugs. CMS names the drug for 69 of them, across 4 drugs with 11 or more claims each, at $374 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Reynolds for performance year 2024, reported as part of a group. Dr. Reynolds accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 3 general payments to Dr. Reynolds from 2 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $232.